People who should exercise caution when using these medications include those with diabetic retinopathy, pancreatitis, gallbladder disease, kidney issues, and stomach or intestinal disorders, such as gastroparesis and digestion problems
Decreased exercise tolerance during treatment was linked with greater lean body mass loss in both groups, but to a greater extent in tirzepatide-treated patients
However, there are risk factors that may increase the chance of developing atrial fibrillation, including (4;11): Age greater than 65 High blood pressure Obesity European ancestry Diabetes Sleep apnea Heart failure Ischemic heart disease Hyperthyroidism Chronic kidney disease Moderate to heavy alcohol use Illicit drug use Smoking Enlargement of the chambers on the left side of the heart Ask yourself
10.1038/s41467-023-38401-z 124 PerisI.Romero-MurilloS.Martnez-BalsalobreE.FarringtonC
Until that evidence is available, these medications remain outside the scope of standard oncology practice for this indication
Post, S.M., de Crom, R., van Haperen, R., van Tol, A